Something shifted this year in how Congress views celiac disease research. When Senator Richard Blumenthal of Connecticut led his annual sign-on letter to the Senate Appropriations Committee in support of celiac disease research funding, he secured the strongest level of Senate support the effort has ever seen. The letter, detailed in a recent announcement from the Celiac Disease Foundation, calls for continued National Institutes of Health (NIH) funding for celiac disease research and urges that the condition remain eligible under the Department of Defense’s Peer-Reviewed Medical Research Program (PRMRP) for Fiscal Year 2027.
This isn’t just ceremonial. These sign-on letters play a direct role in the appropriations process, helping ensure that Congress recognizes celiac disease as a priority worthy of federal research dollars. For families like mine, that matters enormously. Every breakthrough in diagnosis, treatment, or potential therapy starts with funded research.
Why This Year’s Letter Stands Out
Senator Blumenthal has championed this effort annually on behalf of the celiac community, but 2026 marks a historic high-water mark for Senate participation. The record number of senators who added their names to this year’s letter signals growing recognition of celiac disease as a serious autoimmune condition that affects millions of Americans and demands sustained research investment.
The letter targets two critical funding streams. First, it emphasizes the importance of continued NIH support for celiac disease research. The NIH remains the primary source of federal funding for biomedical research in the United States, and dedicated appropriations ensure that celiac disease studies compete on equal footing with other conditions. Second, the letter urges that celiac disease remain eligible under the Department of Defense’s PRMRP, a competitive grant program that funds research into diseases and conditions affecting service members and their families.
As we covered in our piece on how federal research funding is advancing celiac disease science, these federal dollars have fueled progress on everything from improved diagnostic tools to experimental therapies that could one day offer alternatives to the gluten-free diet.
The Role of Grassroots Advocacy
This level of Senate support didn’t materialize on its own. It reflects sustained advocacy efforts by celiac disease patients, families, and organizations who have made their voices heard on Capitol Hill. The Celiac Disease Foundation’s recent 2026 Advocacy Summit brought advocates from across the country to Washington to meet directly with lawmakers and their staff, educating them about the daily realities of living with celiac disease and the urgent need for research funding.
When advocates show up year after year with a consistent message, lawmakers take notice. The record Senate participation in this year’s sign-on letter proves that advocacy works.
For those of us raising children with celiac disease, these efforts carry personal weight. My son depends on a strict gluten-free diet because it’s the only treatment available. But that treatment is imperfect. Cross-contact risks are everywhere. Social events become logistical challenges. The cognitive load of vigilance never stops. Research funding offers the only pathway to better diagnostic tools, improved treatments, and perhaps one day, a cure.
What Federal Research Funding Supports
Federal research dollars support the kind of ambitious, long-term science that private funding rarely can. NIH grants fund university researchers investigating the genetic and immunological mechanisms underlying celiac disease, studies examining why some people develop the condition while others with the same genetic risk factors do not, and clinical trials testing potential therapies.
The Department of Defense’s PRMRP, meanwhile, has proven particularly valuable for celiac disease research because it prioritizes conditions that affect military readiness and the health of service members and their families. Celiac disease can impact service members directly, and many military families navigate the challenges of managing the condition while dealing with frequent relocations, limited access to specialty care, and the constraints of military dining facilities.
Together, these funding streams create an ecosystem where researchers can pursue groundbreaking work. That includes studies into non-dietary therapies, better understanding of refractory celiac disease, improved screening protocols, and investigations into environmental triggers that might help explain why celiac disease prevalence has been rising.
The Appropriations Process Ahead
Sign-on letters are one piece of a larger appropriations process. Over the coming months, the Senate Appropriations Committee will consider funding levels for various programs and agencies, including the NIH and the Department of Defense. The strong Senate support reflected in this year’s letter strengthens the case for prioritizing celiac disease research in those deliberations.
Advocacy doesn’t stop with the sign-on letter. As the appropriations process moves forward, continued engagement from the celiac community—through calls, emails, and meetings with congressional offices—helps keep celiac disease on lawmakers’ radar.
For families navigating celiac disease, it’s easy to feel powerless. We can’t control whether schools understand cross-contact protocols. We can’t force restaurants to take our concerns seriously. We can’t eliminate the risk that a well-meaning grandparent will offer our children something unsafe. But we can advocate for the research that might one day change the landscape entirely.
Looking Forward
The record Senate support for celiac disease research funding in 2026 represents meaningful progress, but it’s progress that needs to be sustained and built upon. Research funding isn’t guaranteed from year to year. It requires ongoing advocacy, public awareness, and political will.
The Celiac Disease Foundation and other advocacy organizations continue to provide resources for individuals who want to engage with this work. Becoming a policy advocate doesn’t require extensive political experience—it requires showing up, sharing your story, and making it clear to elected officials that celiac disease research is a priority for their constituents.
For those of us who watch our children navigate a world not designed for their medical reality, this kind of advocacy offers a tangible way to contribute to change. We can’t cure celiac disease in our home kitchens, but we can support the research that’s working toward that goal. We can make our voices heard in the halls of Congress. And we can celebrate when those voices break through, as they clearly did this year.
The record Senate support for this year’s sign-on letter proves that when the celiac community speaks with a unified voice, lawmakers listen. That’s not just encouraging—it’s actionable. It means our advocacy matters. And it means we need to keep going.
Related Coverage
- Advocates Make History with Record Senate Support for Celiac Disease Research
- Celiac Disease Advocates Take to Capitol Hill for our 2026 Advocacy Summit
- How Federal Research Funding Is Advancing Celiac Disease Science
References
- Celiac Disease Foundation. “Advocates Make History with Record Senate Support for Celiac Disease Research.” May 12, 2026. https://celiac.org/2026/05/12/advocates-make-history-with-record-senate-support-for-celiac-disease-research/